Please use this identifier to cite or link to this item: http://hdl.handle.net/2067/1453
DC FieldValueLanguage
dc.contributor.authorPavan, Barbara-
dc.contributor.authorFiorini, Sara-
dc.contributor.authorDal Monte, Massimo-
dc.contributor.authorLunghi, Laura-
dc.contributor.authorBiondi, Carla-
dc.contributor.authorBagnoli, Paola-
dc.contributor.authorCervia, Davide-
dc.date.accessioned2011-03-21T12:53:50Z-
dc.date.available2011-03-21T12:53:50Z-
dc.date.issued2004-
dc.identifier.citationPavan, B. et al. 2004. Somatostatin coupling to adenylyl cyclase activity in the mouse retina. "Naunyn-Schmiedeberg's Archives of Pharmacology" 370(2):91-98it
dc.identifier.issn0028-1298-
dc.identifier.urihttp://hdl.handle.net/2067/1453-
dc.descriptionL'articolo è disponibile sul sito dell'editore http://www.springerlink.com/it
dc.description.abstractThe peptide somatostatin-14 (SRIF) acts in the mammalian retina through its distinct receptors (sst1-5). Scarce information is available on SRIF function in the retina, including the elucidation of transduction pathways mediating SRIF action. We have investigated SRIF and SRIF receptor modulation of adenylyl cyclase (AC) activity in both wild type (WT) retinas and sst1 or sst2 knock-out (KO) retinas which are known to over-express sst2 or sst1 receptors, respectively. In WT retinas, application of SRIF compounds does not affect forskolin-stimulated AC activity. In contrast, activation of sst1 or sst2 receptors inhibits AC in the presence of sst2 or sst1 receptor antagonists, respectively. Results from sst1 KO retinas demonstrate that either SRIF or octreotide, pertussis toxin-dependently inhibit AC activity. In contrast, in sst2 KO retinas, neither SRIF nor CH-275, an sst1 receptor agonist, are found to influence AC activity. As revealed by immunoblotting experiments, in sst1 KO retinas, levels of Goα proteins are 60% higher than in WT retinas and this increase in Goα protein levels is concomitant with an increase in sst2A receptor expression. We conclude that interactions between sst1 and sst2 receptors may prevent SRIF effects on AC activity. In addition, we suggest that the density of sst2 receptors and/or Goα proteins may represent the rate-limiting factor for the sst2 receptor-mediated inhibition of AC.it
dc.language.isoenit
dc.publisherSpringer Verlagit
dc.subjectSomatostatinit
dc.subjectReceptor agonists and antagonistsit
dc.subjectTransduction pathwaysit
dc.subjectG proteinsit
dc.subjectKnockout retinait
dc.titleSomatostatin coupling to adenylyl cyclase activity in the mouse retinait
dc.typeArticleit
dc.identifier.doi10.1007/s00210-004-0950-5it
item.fulltextWith Fulltext-
item.grantfulltextopen-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.cerifentitytypePublications-
Appears in Collections:DISA - Archivio della produzione scientifica
Files in This Item:
File Description SizeFormat
Pavan et al 2004 N-S Arch Pharmacol 1.pdf50.26 kBAdobe PDFView/Open
Show simple item record

Page view(s)

10
Last Week
0
Last month
1
checked on Nov 30, 2020

Download(s)

6
checked on Nov 30, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.